Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-043723
Filing Date
2011-08-03
Accepted
2011-08-03 17:06:51
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT v228400_10q.htm 10-Q 928183
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER, FILED PURSUANT TO SECTION 302 OF THE v228400_ex31-1.htm EX-31.1 15946
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER, FILED PURSUANT TO SECTION 302 OF THE v228400_ex31-2.htm EX-31.2 15289
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER, FURNISHED v228400_ex32-1.htm EX-32.1 7884
  Complete submission text file 0001144204-11-043723.txt   3369084

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bnvi-20110630.xml EX-101.INS 504090
6 XBRL TAXONOMY EXTENSION SCHEMA bnvi-20110630.xsd EX-101.SCH 14297
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bnvi-20110630_cal.xml EX-101.CAL 39796
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bnvi-20110630_def.xml EX-101.DEF 89404
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bnvi-20110630_lab.xml EX-101.LAB 85142
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bnvi-20110630_pre.xml EX-101.PRE 98205
Mailing Address 5858 HORTON STREET SUITE 400 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET SUITE 400 EMERYVILLE CA 94608 510-601-2000
BIONOVO INC (Filer) CIK: 0001203957 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33498 | Film No.: 111007666
SIC: 2834 Pharmaceutical Preparations